Amicogen, Inc. (KOSDAQ:092040)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,715.00
+12.00 (0.70%)
Jan 29, 2026, 3:30 PM KST
-57.65%
Market Cap95.23B
Revenue (ttm)87.97B -43.5%
Net Income-63.43B
EPS-1,151.90
Shares Out55.53M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume650,627
Average Volume735,858
Open1,711.00
Previous Close1,703.00
Day's Range1,653.00 - 1,772.00
52-Week Range1,455.00 - 4,990.00
Beta0.39
RSI41.17
Earnings DateMar 19, 2026

About Amicogen

Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company develops, produces, and sells of enzymes and new materials; and produces food-related additives and health functional food. It manufactures and sells of biopharmaceutical materials and resins for purifying pharmaceutical proteins and health and beauty products. In addition, the company offers oral incurable and rare disease treatments, as well as manufactures and sells of pharmaceutical raw materials, animal drugs, human drugs, etc. Th... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 236
Stock Exchange KOSDAQ
Ticker Symbol 092040
Full Company Profile

Financial Performance

In 2024, Amicogen's revenue was 173.60 billion, an increase of 8.57% compared to the previous year's 159.90 billion. Losses were -52.79 billion, 126.7% more than in 2023.

Financial Statements